Modern Dental Europe Ltd. has acquired Permadental Holding B.V. from Foreman Capital
Modern Dental Europe Ltd. (MDL) has acquired Permadental Holding B.V. (Permadental) from Foreman Capital.
MDL produces dental prosthesis for dentists and doctors around the world. The company is part of the Modern Dental Holding Ltd group, one of the largest dental laboratories in the world, with production facilities in Shenzhen, China.
Permadental is the importer and supplier of dental prosthesis in the German market. The company has a track record of serving dentists for over 25 years by supplying them with crowns, bridges, implants and telescopic crowns, all manufactured in China.
Founded by Arent Foch and Guido ter Kuile in 2005, Foreman Capital is an independent investment company focused on investments in European companies that are active in trade, manufacturing and service provision.
Oaklins' team in the Netherlands advised the buyer in this transaction.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more